Portland,OR, Dec. 08, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global vaccine market was estimated at $32.46 billion in 2019 and is expected to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.
Increase in the prevalence of infectious diseases, surge in the number of immunization programs across the globe, and rise in R&D activities to develop new vaccines drive the growth of the global vaccine market. On the other hand, longer timelines required for vaccine production and high cost related to the development of vaccines restrain the growth to some extent. However, growth opportunities in emerging market and rise in healthcare spending create new prospects for the key players in the industry.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/258
Covid-19 Scenario-
- The outbreak of the pandemic led to rise in investments and R&D activities for drugs and vaccines against the virus.
- Also, the World Health Organization (WHO) is encouraging the healthcare organizations across the world to put more emphasis on treatment vaccines, and medication against the novel coronavirus.
The global vaccine market is analyzed across technology type, indication, end user, and region. Based on technology type, the recombinant vaccines & conjugate vaccines segment contributed to around two-fifths of the total market share in 2019, and is anticipated to retain its dominance during the forecast period. The same segment is also expected to register the fastest CAGR of 7.7% from 2020 to 2027.
Based on end-user, the pediatric vaccines segment accounted for nearly half of the total market revenue in 2019, and is projected to rule the roost by the end of 2027. The traveler vaccines segment, on the other hand, is anticipated to grow at the fastest CAGR of 7.3% throughout the forecast period.
Based on region, North America held the major share in 2019, garnering around two-fifths of the global vaccine market. Simultaneously, the Asia-Pacific region would exhibit the largest CAGR of 8.1% from 2020 to 2027. The other regions covered in the study include Europe and LAMEA.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/258
The key market players analyzed in the global vaccine market report include Serum Institute of India Pvt. Ltd., Pfizer, Johnson & Johnson, AstraZenecea plc, GlaxoSmithKline plc, Sanofi Aventis, Merck & Co., Inc., Emergent BioSolutions Inc., and CSL Limited, Novavax, Inc. These market players have taken recourse to several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
Varicella Live Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2018–2026
Pneumonia Vaccine Market: Opportunity Analysis and Industry Forecast, 2018–2025
Influenza Vaccine Market-Global Opportunity Analysis and Industry Forecast, 2019–2026
Meningococcal Vaccine Market -Global Opportunity Analysis and Industry Forecast, 2018–2026
Cancer Vaccines Market-Global Opportunity Analysis and Industry Forecast, 2020–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.